Pagina 1 a partire dal 111 risultati
FIELD OF THE DISCLOSURE
The present disclosure presents a method of folding a fibrillar structure from an unfolded native protein and utilizing the fibrillar structure protein to induce cell apoptosis and as vaccine adjuvants.
BACKGROUND
Studies have found that some proteins form fibrillar
BACKGROUND
1. Technical Field
This document relates to methods and materials involved in treating cancer (e.g., skin cancers such as melanoma). For example, this document relates to methods and materials involved in using complexes containing albumin-containing nanoparticles (e.g., ABRAXANE.RTM.
BACKGROUND
1. Technical Field
This document relates to methods and materials involved in treating cancer (e.g., skin cancers such as melanoma). For example, this document relates to methods and materials involved in using complexes containing albumin-containing nanoparticles (e.g., ABRAXANE.RTM.
BACKGROUND
1. Technical Field
This document relates to methods and materials involved in treating cancer (e.g., skin cancers such as melanoma). For example, this document relates to methods and materials involved in using complexes containing albumin-containing nanoparticles (e.g., ABRAXANE.RTM.
CROSS REFERENCE OF RELATED APPLICATION
This is a non-provisional application that claims the benefit of priority under 35 U.S.C. .sctn. 119 to Chinese application number 21610527097.0, filed Jul. 6, 2016, wherein the entire contents of each of which is expressly incorporated herein by
The invention relates to a method for the treatment of tumors sensitive to Paclitaxel, and more particularly concerns a method by which a significant remission or cure of the tumor, with very low toxic side effects, can be achieved by just a few infusions, each of short duration and spaced apart by
BACKGROUND
1. Technical Field
This document relates to methods and materials involved in treating cancer (e.g., skin cancers such as melanoma). For example, this document relates to methods and materials involved in using complexes containing albumin-containing nanoparticles (e.g., ABRAXANE.RTM.
BACKGROUND
1. Technical Field
This document relates to methods and materials involved in treating cancer (e.g., skin cancers such as melanoma). For example, this document relates to methods and materials involved in using complexes containing albumin-containing nanoparticles (e.g., ABRAXANE.RTM.
PRIOR RELATED APPLICATIONS
This application is a National Phase application of International Application No. PCT/EP2012/072039 filed Nov. 7, 2012, which claims priority to European Patent Application No. 11188495.3, filed Nov. 9, 2011, each of which is incorporated herein by reference in its
BACKGROUND
1. Technical Field
This document relates to methods and materials involved in treating cancer (e.g., skin cancers such as melanoma). For example, this document relates to methods and materials involved in using complexes containing albumin-containing nanoparticles (e.g., ABRAXANE.RTM.
BACKGROUND
The present disclosure is related to making and using fibrillar human serum albumin. (HSA) Fibrillar HSA was shown to cause apoptosis of many types of cancer cells by modulating the Akt signaling pathway, as disclosed in U.S. Pat. No. 7,488,800, which is incorporated by
BACKGROUND
The present disclosure is related to making and using fibrillar human serum albumin. (HSA) Fibrillar HSA was shown to cause apoptosis of many types of cancer cells by modulating the Akt signaling pathway, as disclosed in U.S. Pat. No. 7,488,800, which is incorporated by
BACKGROUND
1. Technical Field
This document relates to methods and materials involved in treating cancer (e.g., skin cancers such as melanoma). For example, this document relates to methods and materials involved in using complexes containing albumin-containing nanoparticles (e.g., ABRAXANE.RTM.
COPYRIGHT NOTICE/PERMISSION
A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure as it appears in the Patent and
FIELD OF THE INVENTION
This disclosure relates to novel compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
STATE OF THE ART
Chemotherapy remains a mainstay for systemic therapy for many types of cancer, including